Korro Bio (KRRO) Misses Q1 EPS by 249c

Korro Bio (NASDAQ: KRRO) reported Q1 EPS of ($2.49). Revenue for the quarter came in at $2.55 million.

For earnings history and earnings-related data on Korro Bio (KRRO) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• Kingsoft Cloud Holdings Limited (KC) 2200 contracts of August 10 puts trade